Brilliant Bio Pharma
Brilliant Bio Pharma is a Hyderabad-based veterinary vaccine and animal health manufacturer producing inactivated and live attenuated vaccines for livestock and companion animals in BSL-3 facilities, sold via pan-India distributors and to the Government of India's FMD immunisation programme.
- Company typePrivate
- Founded1998
- HeadquartersHyderabad, India
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Brilliant Bio Pharma does
Brilliant Bio Pharma Private Limited, headquartered in Hyderabad, India, manufactures veterinary vaccines and animal health products for livestock (cattle, sheep, goats) and companion animals (canines). Its portfolio spans inactivated and live attenuated vaccines targeting Foot-and-Mouth Disease (FMD), rabies, bluetongue, Peste des Petits Ruminants (PPR), sheep pox, haemorrhagic septicaemia, blackquarter, and enterotoxaemia, complemented by animal health products including dry powders, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-parasiticides.
The company operates one of the world's largest Biosafety Level 3 (BSL-3) containment manufacturing facilities, with fully automated 500L to 10KL bioreactors used for propagation of FMD, Bluetongue, and Rabies viruses—reportedly the first deployment of 10KL fermenters for FMD vaccine production in India. Manufacturing processes are ISO 9001:2015 certified and compliant with cGMP, GLP, and OIE (World Organisation for Animal Health) guidelines, and the R&D function is housed in a DSIR-certified laboratory capable of mammalian cell culture propagation in both suspension (100L to 10KL) and adherent systems. Cumulative output has scaled from 230,000 doses in 2005 to over 1.5 billion doses globally, with anti-rabies vaccine capacity at 20 million doses per annum and an automated vial-filling line rated at 60,000 PP vials (equivalent to 3 million doses) per day in open RABS aseptic conditions.
Brilliant Bio Pharma monetises through one-time product sales of vaccines and biologics, distributed across India through a channel comprising a 150-person field force, 12 CFA offices, super distributors, and over 1,000 active distributors serving practising veterinarians, retail and institutional segments, dairy co-operatives, corporate dairies, and NGOs. The company is a main stakeholder in the Government of India's FMD Immunisation Programme and holds Star Export House status for international vaccine exports into emerging markets. No third-party manufacturing, licensing, or subscription revenue is disclosed; pricing is governed by government tenders and distributor agreements.
Brilliant Bio Pharma firmographics
Firmographics- Name
- Brilliant Bio Pharma
- Legal name
- Brilliant Bio Pharma Private Limited
- Website
- https://brilliantbiopharma.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Brilliant Bio Pharma is a Hyderabad-based veterinary vaccine and animal health manufacturer producing inactivated and live attenuated vaccines for livestock and companion animals in BSL-3 facilities, sold via pan-India distributors and to the Government of India's FMD immunisation programme.
- Ownership category
- akta.pro rank
Brilliant Bio Pharma industry classification
Industry- Product category
- Veterinary Vaccines and Biologicals
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Livestock Vaccines (Cattle, Swine, Sheep & Goats) (HLAMAKAB)
- akta.pro secondary industries
- Veterinary Vaccines (Biologics) (HLAMAEAL), Veterinary Vaccines (HLAIAEAH), Vaccine R&D, Clinical/Field Trials & Regulatory Affairs (HLAMAKAM)
Keywords
Where Brilliant Bio Pharma is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Brilliant Bio Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Veterinary Vaccines and Biologicals: Sale of veterinary vaccines and biologicals across bovine, ovine, canine, and other animal species. Revenue generated through product sales to government vaccination programmes, dairy co-operatives, corporate dairies, veterinarians, and distributor networks across India and global markets.
- Animal Health Products (AHPs): Broader portfolio of animal health products including dry powder, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-parasiticides sold alongside vaccines.
- Manufacturing Services: Manufacturing capabilities for third-party or contract vaccine production implied by large-scale BSL-3 facility and 10KL bioreactor capacity, though explicit third-party manufacturing agreements are not disclosed.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels4 records
Brilliant Bio Pharma product offering
Product offeringCore offering
Brilliant Bio Pharma manufactures and sells veterinary vaccines and animal health products for bovines, ovines/caprines, and canines. The portfolio includes inactivated and live attenuated vaccines for Foot-and-Mouth Disease, Rabies, Bluetongue, Haemorrhagic Septicaemia, Blackquarter, PPR, Sheep Pox, and Enterotoxaemia, complemented by dry powder, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-parasiticides. Production occurs in one of the world's largest BSL-3 containment facilities using automated 10KL bioreactors, with annual capacity of 1.5 billion doses.
Product overview
Brilliant Bio Pharma is a veterinary vaccines and animal health products company offering a unified portfolio of biologicals and wellness products for livestock and companion animals. The product range includes vaccines for Bovines (FMD, Haemorrhagic Septicaemia, Blackquarter, Rabies), Ovines/Caprines (Enterotoxaemia, Bluetongue, PPR, Sheep Pox), and Canines (Rabies). The company manufactures veterinary vaccines in BSL-3 certified facilities using automated bioreactors and fermentation technology, producing both individual vaccines and combined formulations. Key products include inactivated vaccines (FMD, Bluetongue, Rabies), live attenuated vaccines (PPR, Sheep Pox), and combined vaccines (FMD+HS, HS+Blackquarter). The portfolio is complemented by biologicals, dry powder, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-paraciticides for comprehensive animal health management.
Differentiator
Problem solved
Functional benefit
Products and services
- Rabies Veterinary Vaccine (Cell Culture), Inactivated IP Inactivated cell culture-based veterinary vaccine for rabies prophylaxis in animals, compliant with Indian Pharmacopoeia (IP) standards, targeted at companion animals and livestock.
- Foot-and-Mouth Disease Vaccine, Inactivated IP Inactivated vaccine for Foot-and-Mouth Disease targeting cattle and other cloven-hoofed animals, manufactured in BSL-3 facility using 10KL fermenters.
- Haemorrhagic Septicaemia Vaccine IP Vaccine for Haemorrhagic Septicaemia caused by Pasteurella multocida in cattle and buffalo.
- Blackquarter Vaccine IP Vaccine for Blackquarter (Blackleg) disease in cattle caused by Clostridium chauvoei.
- Haemorrhagic Septicaemia + Blackquarter Vaccine Combined bivalent vaccine providing protection against both Haemorrhagic Septicaemia and Blackquarter in cattle.
- Enterotoxaemia Vaccine IP Vaccine for Enterotoxaemia (Pulpy Kidney disease) in sheep and goats caused by Clostridium perfringens.
- Bluetongue Vaccine, Inactivated IP Inactivated vaccine for Bluetongue disease in sheep and goats, compliant with Indian Pharmacopoeia standards.
- Peste Des Petits Ruminants Live, Freeze Dried Vaccine IP Live attenuated freeze-dried vaccine for Peste Des Petits Ruminants (PPR) targeting sheep and goats.
- Sheep Pox Vaccine, Live Attenuated IP, Freeze Dried Vaccine IP Live attenuated freeze-dried vaccine for Sheep Pox disease in ovine species.
- Foot-and-Mouth Disease + Haemorrhagic Septicaemia Vaccine Combined vaccine providing simultaneous protection against Foot-and-Mouth Disease and Haemorrhagic Septicaemia in cattle.
Quantifiable outcome
- 1.5 billion doses of animal vaccines delivered globally, grown from 2.30 lakh doses in 2005
- +3 more outcomes
Companies that use Brilliant Bio Pharma
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles5 records
Brilliant Bio Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Brilliant Bio Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Govt. of India (FMD Immunisation Programme)coreBrilliant Bio Pharma is one of the main stakeholders in Govt. of India's FMD Control/Immunisation Programme, supplying FMD vaccines for national vaccination campaigns. This government partnership represents a core strategic relationship for the company.
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
Brilliant Bio Pharma competitors and assessment
Company assessmentBroad incumbents
- Elanco Animal Health: Elanco is a major global animal health company with a livestock vaccines portfolio and a strong presence in emerging markets, competing broadly with Brilliant Bio Pharma in the veterinary biologics and government tender space.
- MSD Animal Health: MSD Animal Health is a global leader in livestock and companion animal vaccines, including FMD and rabies, competing with Brilliant Bio Pharma for share in global veterinary vaccine markets and emerging-market government programmes.
- Ceva Santé Animale: Ceva Santé Animale is a global animal health company with a growing livestock and poultry vaccine business, particularly active in emerging markets where it competes with regional players like Brilliant Bio Pharma in FMD and small-ruminant vaccines.
- Phibro Animal Health: Phibro Animal Health is a global animal health and nutrition company with livestock vaccines and health products, competing with Brilliant Bio Pharma in dairy and livestock segments, especially across Asia and the Middle East.
- Zoetis: Zoetis is the world's largest animal health company with a broad portfolio of livestock and companion animal vaccines, including FMD, and competes globally with Brilliant Bio Pharma in the veterinary biologics space, especially for emerging-market and government tenders.
- Boehringer Ingelheim Animal Health: Boehringer Ingelheim Animal Health (including the former Merial) is a top-three global animal health player with FMD, rabies, and livestock vaccine franchises that compete with Brilliant Bio Pharma across emerging markets and global FMD tenders.
Direct peers
- Biovet (Biovet Private Limited): Biovet is an Indian veterinary biologics company producing FMD and livestock vaccines, operating in the same product category as Brilliant Bio Pharma and competing for government and dairy cooperative customers in India.
- Hester Biosciences: Hester Biosciences is an Indian veterinary vaccines and animal health company producing vaccines for poultry, livestock, and companion animals, directly overlapping with Brilliant Bio Pharma's livestock vaccine portfolio and India distribution model.
- Indian Immunologicals Ltd: Indian Immunologicals Ltd is a leading Indian veterinary vaccine manufacturer with a strong FMD vaccine franchise and government programme participation, directly competing with Brilliant Bio Pharma in India's livestock biologics market across cattle, sheep, and goats.
Emerging players
- Vetoquinol: Vetoquinol is a European-headquartered animal health company with livestock and companion animal products, including growing presence in emerging markets where it competes for share with regional vaccine manufacturers like Brilliant Bio Pharma.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Brilliant Bio Pharma social profiles
Digital presenceBrilliant Bio Pharma compliance and trust
Trust signalCompliance4 records
Brilliant Bio Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Brilliant Bio Pharma leadership team
Management profileNumber of profiles
Profiles1 record
Brilliant Bio Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Brilliant Bio Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Brilliant Bio Pharma
What does Brilliant Bio Pharma do?
Brilliant Bio Pharma manufactures and sells veterinary vaccines and animal health products for bovines, ovines/caprines, and canines. The portfolio includes inactivated and live attenuated vaccines for Foot-and-Mouth Disease, Rabies, Bluetongue, Haemorrhagic Septicaemia, Blackquarter, PPR, Sheep Pox, and Enterotoxaemia, complemented by dry powder, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-parasiticides. Production occurs in one of the world's largest BSL-3 containment facilities using automated 10KL bioreactors, with annual capacity of 1.5 billion doses.
Is Brilliant Bio Pharma a public or private company?
Brilliant Bio Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Brilliant Bio Pharma founded?
Brilliant Bio Pharma was founded in 1998. It employs 251 to 500 people.
Where is Brilliant Bio Pharma based?
Brilliant Bio Pharma is headquartered in Hyderabad, India, in the Asia region.
How does Brilliant Bio Pharma make money?
Three revenue lines are on record. Veterinary Vaccines and Biologicals are the primary driver. The others are animal Health Products (AHPs) and manufacturing Services.
Who are Brilliant Bio Pharma's main competitors?
Broad incumbents on record are Elanco Animal Health, MSD Animal Health, Ceva Santé Animale, Phibro Animal Health, Zoetis and Boehringer Ingelheim Animal Health. Direct peers are Biovet (Biovet Private Limited), Hester Biosciences and Indian Immunologicals Ltd. Vetoquinol is listed as an emerging player.
Does Brilliant Bio Pharma have an API?
No public API is recorded for Brilliant Bio Pharma.
What industry is Brilliant Bio Pharma in?
Brilliant Bio Pharma's product category is Veterinary Vaccines and Biologicals. Its primary akta.pro industry code is HLAMAKAB, Livestock Vaccines (Cattle, Swine, Sheep & Goats), with a secondary code of HLAMAEAL, Veterinary Vaccines (Biologics). Its NAICS code is 325414 and its SIC code is 2836.